Search Knowledge Base

14 results for "antifibrinolytic-agents"

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders cochrane_review
Evidence Source 2026 PMID: 41670018
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions pubmed_article
Evidence Source 2018 PMID: 29963686
Melasma: systematic review of the systemic treatments pubmed_article
Evidence Source 2017 PMID: 28239840
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders cochrane_review
Evidence Source 2016 PMID: 26978005
Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases pubmed_article
Evidence Source 2015 PMID: 26058964
Vitamin K for the primary prevention of cardiovascular disease pubmed_article
Evidence Source 2015 PMID: 26389791
Vitamin K for improved anticoagulation control in patients receiving warfarin pubmed_article
Evidence Source 2014 PMID: 24832594
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders cochrane_review
Evidence Source 2013 PMID: 23897323
Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases pubmed_article
Evidence Source 2012 PMID: 22972075
Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage pubmed_article
Evidence Source 2010 PMID: 20091505
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement pubmed_article
Evidence Source 2010 PMID: 20393944
Vitamin K for upper gastrointestinal bleeding in patients with liver diseases pubmed_article
Evidence Source 2008 PMID: 18677778
Vitamin K for upper gastrointestinal bleeding in patients with liver diseases pubmed_article
Evidence Source 2005 PMID: 16034950
Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage pubmed_article
Evidence Source 2001 PMID: 11279686

Evidence Search Results semantic · quality-ranked

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders meta_analysis cochrane_review
Quality: 80 2026 PMID: 41670018 DOI: 10.1002/14651858.CD009733.pub4
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome meta_analysis pubmed_article
Quality: 77 2020 PMID: 33045766 DOI: 10.1002/14651858.CD012169.pub3
Antiplatelet agents and anticoagulants for hypertension systematic_review pubmed_article
Quality: 76 2022 PMID: 35900898 DOI: 10.1002/14651858.CD003186.pub4
Efficacy and safety of DOACs vs vitamin K antagonists in patients with atrial fibrillation and chronic kidney disease undergoing hemodialysis: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis meta_analysis pubmed_article
Quality: 62 2025 PMID: 39923948 DOI: 10.1016/j.hrthm.2025.02.009
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 58 2015 PMID: 26037103 DOI: 10.1136/heartjnl-2015-307489
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis systematic_review pubmed_article
Quality: 72 2017 PMID: 29183961 DOI: 10.1136/bmj.j5058
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation meta_analysis pubmed_article
Quality: 75 2013 PMID: 23925867 DOI: 10.1002/14651858.CD008980.pub2
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation meta_analysis pubmed_article
Quality: 76 2018 PMID: 29509959 DOI: 10.1002/14651858.CD008980.pub3
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders meta_analysis cochrane_review
Quality: 72 2016 PMID: 26978005 DOI: 10.1002/14651858.CD009733.pub3
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome meta_analysis pubmed_article
Quality: 78 2017 PMID: 28968483 DOI: 10.1002/14651858.CD012169.pub2

View full evidence search →